Lindsay Pharmaceutical Private Limited
About Lindsay Pharmaceutical Private Limited
Data last updated:
Lindsay Pharmaceutical Private Limited is a private limited company based in Patna, Bihar, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U51909BR2020PTC044892. Its GSTIN is 10AAECL1276C1Z6 (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8 Lakh. It is led by directors Nicky Kumari and Chandan Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at T 562 Housing Colony 2nd Floor Kankarbagh, Patna, Bihar, India – 800020.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.1 Cr, a growth of 42% compared to the previous year. For the same year it recorded a net profit of ₹28.86 Lakh (net margin 26.2%) and EBITDA of ₹38.95 Lakh (EBITDA margin 35.4%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years.
Company details
Contact details
Lindsay Pharmaceutical Private Limited's registered office is in Patna, Bihar.
- Registered AddressT 562 Housing Colony 2nd Floor Kankarbagh, Patna, Bihar, India – 800020
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Lindsay Pharmaceutical Private Limited
FY 2025 filings availableLindsay Pharmaceutical Private Limited reported revenue of ₹1.1 Cr (up 42% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 26% over three years, including 42% growth in the latest year. EBITDA rose 155% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹38.95 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹28.86 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 35.4% | ||||
| Net Profit Margin | 26.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lindsay Pharmaceutical Private Limited, buy the company report.
Board of directors of Lindsay Pharmaceutical Private Limited
Lindsay Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nicky Kumari | Director | 12 Feb 2021 | 5 Years 8 Months | Current |
| Chandan Yadav | Director | 21 Jul 2025 | 1 Years 3 Months | Current |
Peer comparison
Lindsay Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Walfs Pharma Private Limited | ₹1.11 Cr (FY 2025) | 26.0% | Chennai, Tamil Nadu, India | |||
| Ajit Laboratories Limited | ₹1.11 Cr (FY 2025) | 6.0% | Sangli, Maharashtra, India | |||
| Biocare Remedies Pvt Ltd | ₹1.1 Cr (FY 2024) | Gandhinagar, Gujarat, India | ||||
| Khevo Pharmaceuticals Private Limited | ₹1.1 Cr (FY 2025) | 45.0% | Pune, Maharashtra, India | |||
| Neuheit Pharma Private Limited | ₹1.1 Cr (FY 2020) | 935.0% | Hyderabad, Telangana, India | |||
| Lindsay Pharmaceutical Private Limitedthis company | ₹1.1 Cr (FY 2025) | ₹28.86 Lakh | 26.2% | 42.0% | Patna, Bihar, India | |
| Zeuson Medicines Private Limited | ₹1.1 Cr (FY 2024) | 44.0% | Bangalore, Karnataka, India | |||
| Svi Healthcare Private Limited | ₹1.1 Cr (FY 2022) | -30.0% | Panipat, Haryana, India | |||
| R.K.Medicare Private Limited | ₹1.1 Cr (FY 2024) | 306.0% | Mumbai, Maharashtra, India | |||
| Addition Aromatics Chemical Private Limited | ₹1.09 Cr (FY 2025) | -69.0% | Ahmedabad, Gujarat, India | |||
| Aronation Life Care Private Limited | ₹1.09 Cr (FY 2022) | 474.0% | Kangra, Himachal Pradesh, India |
To see the full peer comparison of Lindsay Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lindsay Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lindsay Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lindsay Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAECL1276C1Z6 | Bihar | Active | 15 Sep 2020 |
To see the full GST registrations and return filing status of Lindsay Pharmaceutical Private Limited, buy the company report.
Recent activity
Lindsay Pharmaceutical Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Archna Kumari ceased to be Director on 30 Jul 2025.
Frequently asked questions
Lindsay Pharmaceutical is an active private limited company based in Patna, Bihar, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 January 2020 (6+ years old) and is registered under CIN U51909BR2020PTC044892.
Lindsay Pharmaceutical has 2 current directors:
- Nicky Kumari - Director
- Chandan Yadav - Director
The latest financial statements of Lindsay Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Lindsay Pharmaceutical is 10AAECL1276C1Z6, registered in Bihar.
The CIN (Corporate Identification Number) of Lindsay Pharmaceutical is U51909BR2020PTC044892. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lindsay Pharmaceutical was incorporated on 07 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Lindsay Pharmaceutical by revenue are Walfs Pharma Private Limited, Ajit Laboratories Limited, Biocare Remedies Pvt Ltd, Khevo Pharmaceuticals Private Limited, Neuheit Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Archna Kumari ceased to be Director on 30 Jul 2025. Khushbu Kumari ceased to be Director on 30 Jul 2025. Chandan Yadav was appointed as Director on 21 Jul 2025. Lindsay Pharmaceutical has 4 board changes on record in total.
The registered office of Lindsay Pharmaceutical is at T 562 Housing Colony 2nd Floor Kankarbagh, Patna, Bihar, India – 800020.
Lindsay Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
Lindsay Pharmaceutical can be reached at its registered office: T 562 Housing Colony 2nd Floor Kankarbagh, Patna, Bihar, India – 800020.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
